Since BRCA1 mutations have been consistently associated with increased risk of triple negative breast cancer, Paranjape and colleagues evaluated whether the observed association of the KRAS variant with premenopausal triple negative breast cancer was only due to its association with carriers of BRCA1 mutation. Here, KRAS is linked to triple-negative breast carcinoma.